News
CLPBY
5.75
+0.88%
0.05
Weekly Report: what happened at CLPBY last week (0622-0626)?
Weekly Report · 2d ago
Weekly Report: what happened at CLPBY last week (0615-0619)?
Weekly Report · 06/22 09:28
Weekly Report: what happened at CLPBY last week (0608-0612)?
Weekly Report · 06/15 09:28
Weekly Report: what happened at CLPBY last week (0601-0605)?
Weekly Report · 06/08 09:26
Weekly Report: what happened at CLPBY last week (0525-0529)?
Weekly Report · 06/01 09:28
Weekly Report: what happened at CLPBY last week (0518-0522)?
Weekly Report · 05/25 09:29
Weekly Report: what happened at CLPBY last week (0511-0515)?
Weekly Report · 05/18 09:29
Coloplast: Went 'BUY' A Bit Early
Seeking Alpha · 05/16 14:37
Coloplast A/S reports Q2 results
Seeking Alpha · 05/12 18:52
Coloplast Q2 2026 Earnings Call: Complete Transcript
Benzinga · 05/12 10:07
Coloplast Raises FY2026 Sales Guidance from $4.541B to $4.587B-$4.630B vs $4.540B Est
Benzinga · 05/12 10:05
Coloplast Q2 Adj. EPS $0.10 Beats $0.09 Estimate, Sales $1.110B Beat $1.100B Estimate
Benzinga · 05/12 10:00
Coloplast Slips To Loss In Q2 On Hefty Charge, Revenues Rise; Confirms FY26 Outlook
NASDAQ · 05/12 09:46
Weekly Report: what happened at CLPBY last week (0504-0508)?
Weekly Report · 05/11 09:28
Weekly Report: what happened at CLPBY last week (0427-0501)?
Weekly Report · 05/04 09:27
Weekly Report: what happened at CLPBY last week (0420-0424)?
Weekly Report · 04/27 09:28
Coloplast H1 Profit Before Special Items Rises; Revises FY Financial Guidance
NASDAQ · 04/24 04:48
Weekly Report: what happened at CLPBY last week (0413-0417)?
Weekly Report · 04/20 09:27
Weekly Report: what happened at CLPBY last week (0406-0410)?
Weekly Report · 04/13 09:28
Weekly Report: what happened at CLPBY last week (0330-0403)?
Weekly Report · 04/06 09:28
More
Webull provides a variety of real-time CLPBY stock news. You can receive the latest news about Coloplast As Drc through multiple platforms. This information may help you make smarter investment decisions.
About CLPBY
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.